Innovus Pharmaceuticals, Inc. (INNV) EPS Estimated At $-0.01 as of April, 1

Innovus Pharmaceuticals, Inc. (OTCMKTS:INNV) is expected to reveal earnings on April, 1., according to RTT. earnings per share of $-0.01 is 0.00 % from 2018’s $-0.01 EPS. 0.00 % EPS growth is what analysts predict. $-0.01 earnings per share was announced for last quarter. INNV touched $0.0517 during the last trading session after $0.0057 change.Innovus Pharmaceuticals, Inc. has volume of 30,000 shares. Since March 14, 2018 INNV has 0.00% and is . INNV underperformed by 4.37% the S&P 500.

Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the commercialization, licensing, and development of non-prescription medicine and consumer care products in the United States.The firm is valued at $12.66 million. The Company’s products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph-compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream that enhances penile sensitivity; Zestra Glide, a water longer lasting lubricant; Vesele, a proprietary oral supplement of Arginine sexual and cognitive functions; and Androferti, a natural supplement to support overall male reproductive health and sperm quality.Last it reported negative earnings. The firm also offers Beyond Human testosterone booster, Ketones, krill oil, Omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; and UriVarx, a proprietary supplement for overactive bladder and urinary incontinence.

For more Innovus Pharmaceuticals, Inc. (OTCMKTS:INNV) news posted recently go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Innovus Pharma merges with Novalere FP, nabs rights to steroid nasal spray – Seeking Alpha” posted on February 05, 2015, “Innovus Pharma’ Diabasens OK’d in Canada – Seeking Alpha” on March 01, 2019, “Innovus Pharma expands into CBD oil-based products market – Seeking Alpha” with a publish date: October 18, 2018, “Innovus Pharmaceuticals announces $3.17M private placement – Seeking Alpha” and the last “Innovus Pharmaceuticals (INNV) Investor Presentation – Slideshow – Seeking Alpha” with publication date: June 19, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.